الشرق اللبنانية
Source: الشرق اللبنانية
2 Daysالشرق اللبنانية
Source: الشرق اللبنانية
2 DaysReady to play
Ready to play
The Director General of the National Social Security Fund, Mohammad Karki, reassured insured members that the Fund’s decisions are part of efforts to improve services, simplify procedures, and ease financial burdens. On November 10, 2026, the Fund issued three circulars expanding health benefits and increasing their value. Circular No. 854 raised the Fund’s contribution toward medication for myasthenia gravis from 80% to 95%, effective November 5. Circular No. 855 added coverage for premature infants and newborns and set the fees for consultations during treatment. The statement also noted that revisions to medicine prices and medical and hospital tariffs were in their final stages.
Notice: This Is an AI-Generated Summary
Comments (0)